This vial contains a new drug called PAC-832, which I recently invented to treat Alzheimer’s disease. It is the world’s first selective GalR1 antagonist.
I designed and synthesized PAC-832 in a chemistry lab I built in my garage. (1/16) https://t.co/J72K43yvlX
Well, unfortunately the only real test to treat AD is in a phase 3 human trial. We have animal models but the correlation to humans is, so far, very bad. Every time we’ve cured it in a mouse it hasn’t worked in people.
Thank you for taking the time to explain it. It sounds like they need to publish so that their work can be checked.
Well, unfortunately the only real test to treat AD is in a phase 3 human trial. We have animal models but the correlation to humans is, so far, very bad. Every time we’ve cured it in a mouse it hasn’t worked in people.